Genetic Insights into Parkinson's Disease Mechanisms

Parkinson’s disease is a complex neurodegenerative disorder in which both rare, high-penetrance mutations and common, low-risk variants contribute to individual susceptibility, age at onset and progression. Monogenic forms arising from mutations in genes such as SNCA, LRRK2, VPS35, PRKN, PINK1, DJ-1 and GBA have elucidated fundamental pathways in protein aggregation, mitochondrial quality control and lysosomal degradation. Concurrently, large-scale genome-wide association studies have identified over ninety independent risk loci, many of which implicate vesicular trafficking, neuroinflammation and synaptic function. Fine-mapping of these loci coupled with expression quantitative trait locus analyses has begun to assign causal genes and cell types, while emerging work in diverse ancestral groups reveals population-specific risk alleles that modulate both global and regional disease burden. Together, these genetic insights are driving a transition from descriptive epidemiology to mechanistic understanding, thereby informing biomarker development, patient stratification and the design of targeted therapeutic strategies on a global scale.

Research from Nature Portfolio

Recent large-scale multi-ancestry meta-analysis involving over 49,000 Parkinson’s cases and more than 2.4 million controls has extended the genetic architecture of disease beyond single-population studies. Researchers identified 78 independent genome-wide significant loci, including 12 novel regions, and fine-mapped six known loci to pinpoint putative causal variants. Integration with publicly available gene expression data yielded 25 candidate genes whose altered transcription is associated with disease risk. This cross-ancestry approach not only enhances locus discovery power but also refines causal inference by leveraging differences in linkage disequilibrium, establishing a robust framework for downstream functional characterisation.

Genetic Insights into Parkinson's Disease Mechanisms publication trend

The graph below shows the total number of articles in genetic insights into parkinson's disease mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Genome-wide association study (GWAS): Unbiased analysis of genetic variants across the genome to identify loci associated with disease risk.

Locus: Specific region on a chromosome where genetic variants influence a trait or disease susceptibility.

Fine-mapping: High-resolution analysis to localise the most likely causal variant(s) within a risk locus.

Expression quantitative trait locus (eQTL): A genomic region where variation correlates with changes in gene expression levels.

Monogenic Parkinson’s disease: Form of PD caused by a single pathogenic variant with high penetrance, often following Mendelian inheritance.

Penetrance: The proportion of individuals carrying a particular genetic variant who exhibit the associated phenotype.

References

1. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study. The Lancet Neurology (2023).
2. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease. Nature Genetics (2023).
3. Genetics of Parkinson's disease: An introspection of its journey towards precision medicine. Neurobiology of Disease (2020).
4. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Movement Disorders (2023).